When the log rank p value was obtained for cyclin D2 low vs. high expressers, it was statistically significant in LUAD, PAAD, BRCA, and GBM (Fig. 7B1–4), but not in ESCA (Fig. 7B5), and a low hazard ratio (<1) was observed in all tumor types. The gene discussed is CCND2; the disease is glioblastoma.